Trial intelligence / Profile preview

PPOS vs GnRH Antagonist Protocol in IVF

NCT03680053Terminated

Sponsor
Shanghai Ji Ai Genetics & IVF Institute
Start
Apr 2020
Primary completion
May 2025
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, open-label trial of dydrogesterone in infertility (2 arms), sponsored by Shanghai Ji Ai Genetics & IVF Institute. Primary endpoint: Live birth rate of the first FET at 1 year. Started Apr 2020; status: terminated.

02

Drugs

dydrogesterone
03

Conditions

infertility

Beyond the preview

Go deeper on NCT03680053.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03680053.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call